Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Randall B Meacham

Showing results (51-60 of 60) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 60 results.
American Journal of Cancer Research|October 5, 2011
Molecular aspects of renal cell carcinoma: a reviewHari Koul, Jung-Sik Huh, Kyle O Rove, et al.
Cancer Research|December 16, 2022
Editor's Note: p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 ActivityBinod Kumar, Sweaty Koul, Jane Petersen, et al.
Cancer Research|January 14, 2010
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activityBinod Kumar, Sweaty Koul, Jane Petersen, et al.
Molecular Cancer|June 17, 2010
Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEFThomas R Johnson, Sweaty Koul, Binod Kumar, et al.
Molecular Cancer|August 28, 2021
Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEFThomas R Johnson, Sweaty Koul, Binod Kumar, et al.
The Journal of Urology|October 25, 2011
Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitroAbdalla Ali Deb, Shandra S Wilson, Kyle O Rove, et al.
Molecular Cancer Research : MCR|October 17, 2008
Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancerThomas R Johnson, Lakshmipathi Khandrika, Binod Kumar, et al.
The Journal of Surgical Research|July 23, 2011
The computerized rounding report: implementation of a model system to support transitions of careMax V Wohlauer, Kyle O Rove, Thomas J Pshak, et al.
Plos One|September 18, 2012
The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiationRebecca E Oberley-Deegan, Joshua J Steffan, Kyle O Rove, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2013
Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levelsKerry L Hildreth, Daniel W Barry, Kerrie L Moreau, et al.
Pageof 6

Showing results (51-60 of 60) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
American Journal of Cancer Research|October 5, 2011
Molecular aspects of renal cell carcinoma: a reviewHari Koul, Jung-Sik Huh, Kyle O Rove, et al.
Cancer Research|December 16, 2022
Editor's Note: p38 Mitogen-Activated Protein Kinase-Driven MAPKAPK2 Regulates Invasion of Bladder Cancer by Modulation of MMP-2 and MMP-9 ActivityBinod Kumar, Sweaty Koul, Jane Petersen, et al.
Cancer Research|January 14, 2010
p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activityBinod Kumar, Sweaty Koul, Jane Petersen, et al.
Molecular Cancer|June 17, 2010
Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: regulation of MMP 9 by PDEFThomas R Johnson, Sweaty Koul, Binod Kumar, et al.
Molecular Cancer|August 28, 2021
Retraction Note to: Loss of PDEF, a prostate-derived Ets factor is associated with aggressive phenotype of prostate cancer: Regulation of MMP 9 by PDEFThomas R Johnson, Sweaty Koul, Binod Kumar, et al.
The Journal of Urology|October 25, 2011
Potentiation of mitomycin C tumoricidal activity for transitional cell carcinoma by histone deacetylase inhibitors in vitroAbdalla Ali Deb, Shandra S Wilson, Kyle O Rove, et al.
Molecular Cancer Research : MCR|October 17, 2008
Focal adhesion kinase controls aggressive phenotype of androgen-independent prostate cancerThomas R Johnson, Lakshmipathi Khandrika, Binod Kumar, et al.
The Journal of Surgical Research|July 23, 2011
The computerized rounding report: implementation of a model system to support transitions of careMax V Wohlauer, Kyle O Rove, Thomas J Pshak, et al.
Plos One|September 18, 2012
The antioxidant, MnTE-2-PyP, prevents side-effects incurred by prostate cancer irradiationRebecca E Oberley-Deegan, Joshua J Steffan, Kyle O Rove, et al.
The Journal of Clinical Endocrinology and Metabolism|March 28, 2013
Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levelsKerry L Hildreth, Daniel W Barry, Kerrie L Moreau, et al.
Pageof 6